The global pandemic caused by the newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused worldwide suffering and death of unimaginable magnitude from coronavirus disease 2019 (COVID-19). The virus is transmitted through aerosol droplets, and causes severe acute respiratory syndrome. SARS-CoV-2 uses the receptor-binding domain of its spike protein S1 to attach to the host angiotensin-converting enzyme 2 receptor in lung and airway cells. Binding requires the help of another host protein, transmembrane protease serine S1 member 2. Several factors likely contribute to the efficient transmission of SARS-CoV-2. The receptor-binding domain of SARS-CoV-2 has a 10- to 20-fold higher receptor-binding capacity compared with previous pandemic coronaviruses. In addition, because asymptomatic persons infected with SARS-CoV-2 have high viral loads in their nasal secretions, they can silently and efficiently spread the disease. PCR-based tests have emerged as the criterion standard for the diagnosis of infection. Caution must be exercised in interpreting antibody-based tests because they have not yet been validated, and may give a false sense of security of being "immune" to SARS-CoV-2. We discuss how the development of some symptoms in allergic rhinitis can serve as clues for new onset COVID-19. There are mixed reports that asthma is a risk factor for severe COVID-19, possibly due to differences in asthma endotypes. The rapid spread of COVID-19 has focused the efforts of scientists on repurposing existing Food and Drug Administration approved drugs that inhibit viral entry, endocytosis, genome assembly, translation, and replication. Numerous clinical trials have been launched to identify effective treatments for COVID-19. Initial data from a placebo-controlled study suggest faster time to recovery in patients on remdesivir; it is now being evaluated in additional controlled studies. As discussed in this review, till effective vaccines and treatments emerge, it is important to understand the scientific rationale of pandemic-mitigation strategies such as wearing facemasks and social distancing, and implement them.
机构:
Hosp Luz Lisboa, Immunoallergy Dept, Lisbon, Portugal
Nova Univ Lisbon, Chron Dis Res Ctr, NOVA Med Sch, Lisbon, Portugal
Nova Univ Lisbon, Comprehens Hlth Res Ctr, NOVA Med Sch, Lisbon, PortugalHosp Luz Lisboa, Immunoallergy Dept, Lisbon, Portugal
机构:
Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Huang, Yuling
Yang, Shujuan
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China
Sichuan Univ, West China Fourth Hosp, Chengdu, Peoples R China
Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Yang, Shujuan
Zou, Yuxuan
论文数: 0引用数: 0
h-index: 0
机构:
Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Zou, Yuxuan
Su, Jianming
论文数: 0引用数: 0
h-index: 0
机构:
Hlth Commiss Sichuan Prov, Chengdu, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Su, Jianming
Wu, Canglang
论文数: 0引用数: 0
h-index: 0
机构:
Hlth Informat Ctr Sichuan Prov, Chengdu, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Wu, Canglang
Zhong, Bo
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
Zhong, Bo
Jia, Peng
论文数: 0引用数: 0
h-index: 0
机构:
Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R China
Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Peoples R ChinaSichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China
机构:
Univ New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
Univ New Mexico, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USAUniv New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
Teixeira, J. Pedro
Barone, Sharon
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
New Mexico Vet Healthcare Med Ctr, Med Res Serv, Albuquerque, NM 87108 USAUniv New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
Barone, Sharon
Zahedi, Kamyar
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
New Mexico Vet Healthcare Med Ctr, Med Res Serv, Albuquerque, NM 87108 USAUniv New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
Zahedi, Kamyar
Soleimani, Manoocher
论文数: 0引用数: 0
h-index: 0
机构:
Univ New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
New Mexico Vet Healthcare Med Ctr, Med Res Serv, Albuquerque, NM 87108 USAUniv New Mexico, Div Nephrol, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
机构:
Univ Tokyo, Res Ctr Adv Sci & Technol RCAST, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, JapanUniv Tokyo, Res Ctr Adv Sci & Technol RCAST, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan